Millennium Management’s Audentes Therapeutics, Inc BOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-536,873
| Closed | -$32.1M | – | 4890 |
|
|
2019
Q4 | $32.1M | Sell |
536,873
-236,406
| -31% | -$8.87M | 0.04% | 568 |
|
|
2019
Q3 | $21.7M | Buy |
773,279
+255,086
| +49% | +$8.71M | 0.03% | 723 |
|
|
2019
Q2 | $19.6M | Sell |
518,193
-192,616
| -27% | -$7.4M | 0.03% | 799 |
|
|
2019
Q1 | $27.7M | Buy |
710,809
+119,835
| +20% | +$3.44M | 0.04% | 607 |
|
|
2018
Q4 | $12.6M | Buy |
+590,974
| New | +$15.2M | 0.02% | 984 |
|
|
2018
Q3 | – | Sell |
-337,055
| Closed | -$12.9M | – | 4483 |
|
|
2018
Q2 | $12.9M | Buy |
337,055
+125,707
| +59% | +$4.66M | 0.02% | 1152 |
|
|
2018
Q1 | $6.35M | Buy |
+211,348
| New | +$7.16M | 0.01% | 1647 |
|
|
2017
Q4 | – | Sell |
-121,275
| Closed | -$3.4M | – | 4234 |
|
|
2017
Q3 | $3.4M | Sell |
121,275
-60,095
| -33% | -$1.3M | 0.01% | 1877 |
|
|
2017
Q2 | $3.47M | Buy |
181,370
+94,933
| +110% | +$1.52M | 0.01% | 1738 |
|
|
2017
Q1 | $1.47M | Sell |
86,437
-1,318
| -2% | -$21.3K | ﹤0.01% | 2178 |
|
|
2016
Q4 | $1.6M | Buy |
+87,755
| New | +$1.52M | ﹤0.01% | 2011 |
|
Millennium Management's BOLD Position: Q1 2020 in Review
Millennium Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 536,873 shares — an estimated $32.1M sold.
Millennium Management first reported a position in BOLD in Q4 2016 and held it in 11 quarters. The position peaked at $32.1M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.
- Millennium Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
- Millennium Management sold 536,873 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $32.1M.
- Millennium Management first reported a position in Audentes Therapeutics, Inc in Q4 2016 and held it in 11 quarters.
- Millennium Management's Audentes Therapeutics, Inc position peaked at $32.1M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.